Free Trial

Cardiff Oncology (CRDF) SEC Filings & 10K Form

Cardiff Oncology logo
$3.66 +0.07 (+1.84%)
Closing price 07/3/2025 03:55 PM Eastern
Extended Trading
$3.64 -0.02 (-0.44%)
As of 07/3/2025 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Cardiff Oncology SEC Filings

DateFilerForm TypeView
06/30/2025
8:38 AM
Cardiff Oncology, Inc. (Issuer)
Cardiff Oncology (Issuer)
Mohindru Mani (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2025
8:38 AM
Cardiff Oncology, Inc. (Issuer)
Cardiff Oncology (Issuer)
Markin Rodney S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2025
8:39 AM
Cardiff Oncology, Inc. (Issuer)
Cardiff Oncology (Issuer)
TANNENBAUM RENEE P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2025
7:45 PM
Armitage James O (Reporting)
Cardiff Oncology, Inc. (Issuer)
Cardiff Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2025
6:38 PM
Cardiff Oncology, Inc. (Issuer)
Cardiff Oncology (Issuer)
PACE GARY W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2025
6:40 PM
Cardiff Oncology, Inc. (Issuer)
Cardiff Oncology (Issuer)
White Lale (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
3:30 PM
Cardiff Oncology, Inc. (Filer)
Cardiff Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
11:15 PM
Cardiff Oncology, Inc. (Filer)
Cardiff Oncology (Filer)
Form EFFECT
04/23/2025
7:19 PM
BlackRock, Inc. (Filed by)
Cardiff Oncology, Inc. (Subject)
Cardiff Oncology (Subject)
Form SCHEDULE 13G
02/27/2025
3:11 PM
Cardiff Oncology, Inc. (Filer)
Cardiff Oncology (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/27/2025
3:15 PM
Cardiff Oncology, Inc. (Filer)
Cardiff Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
3:00 PM
Cardiff Oncology, Inc. (Filer)
Cardiff Oncology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2025
1:48 PM
Cardiff Oncology, Inc. (Subject)
Cardiff Oncology (Subject)
PFIZER INC (Filed by)
Form SCHEDULE 13G/A
12/18/2024
3:37 PM
Cardiff Oncology, Inc. (Issuer)
Cardiff Oncology (Issuer)
Levine James E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:06 PM
Cardiff Oncology, Inc. (Subject)
Cardiff Oncology (Subject)
COMMODORE CAPITAL LP (Filed by)
Form SCHEDULE 13G
12/16/2024
4:00 PM
Cardiff Oncology, Inc. (Issuer)
Cardiff Oncology (Issuer)
TANNENBAUM RENEE P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
5:15 AM
Cardiff Oncology, Inc. (Filer)
Cardiff Oncology (Filer)
Form 424B5
12/10/2024
5:02 AM
Cardiff Oncology, Inc. (Filer)
Cardiff Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
1:02 PM
BlackRock, Inc. (Filed by)
Cardiff Oncology, Inc. (Subject)
Cardiff Oncology (Subject)
Form SC 13G
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CRDF) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners